tm logo
THE SUSTAINABLE HEALTHCARE CO
Live/Registered
REGISTERED

on 20 Feb 2024

Last Applicant/ Owned by

30 Florida Ave., N. W., Unit #6

Washington, D. C.

DC

20001

Serial Number

90863643 filed on 03rd Aug 2021

Registration Number

7311964 registered on 20th Feb 2024

in the Supplemental Register

Correspondent Address

Francis G. Gleason Jr.

GLEASON & GLEASON P. C.

10 POST OFFICE SQUARE, SUITE 800 SOUTH

BOSTON,MA 02109

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"HEALTHCARE CO"

THE SUSTAINABLE HEALTHCARE CO

"HEALTHCARE CO" Retail pharmacy services; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting Read More

Classification Information


Class [035]
Advertising, Business & Retail Services


Retail pharmacy services; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies


First Use Date in General

18th Nov 2022

First Use Date in Commerce

18th Nov 2022

Class [005]
Pharmaceutical Products


Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs


First Use Date in General

18th Nov 2022

First Use Date in Commerce

18th Nov 2022

Specimens


THE SUSTAINABLE HEALTHCARE CO specimenTHE SUSTAINABLE HEALTHCARE CO specimenTHE SUSTAINABLE HEALTHCARE CO specimenTHE SUSTAINABLE HEALTHCARE CO specimenTHE SUSTAINABLE HEALTHCARE CO specimenTHE SUSTAINABLE HEALTHCARE CO specimenTHE SUSTAINABLE HEALTHCARE CO specimenTHE SUSTAINABLE HEALTHCARE CO specimenTHE SUSTAINABLE HEALTHCARE CO specimenTHE SUSTAINABLE HEALTHCARE CO specimen

Mark Details


Serial Number

No 90863643

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
20th Feb 2024REGISTERED-SUPPLEMENTAL REGISTER
20th Feb 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
17th Jan 2024NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
16th Jan 2024USE AMENDMENT ACCEPTED
16th Jan 2024APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
26th Dec 2023EXAMINERS AMENDMENT -WRITTEN
26th Dec 2023EXAMINERS AMENDMENT E-MAILED
26th Dec 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26th Dec 2023EXAMINER'S AMENDMENT ENTERED
28th Aug 2023NON-FINAL ACTION WRITTEN